O2H Ventures
- Investor (buy-side or sell-side research)
- Biotech or pharma, therapeutic R&D
- CMO, CRO
The o2h Group seeds new ideas in life sciences, technology, and green innovation through a unique, multi-faceted ecosystem built by founders with over 40 years of combined experience in entrepreneurship, investment, and drug discovery.
The group comprises o2h Ventures, an investment firm focused on biotech and healthtech. It has now invested in 35 biotech companies and continues to actively support disruptive science-led innovation. o2h Discovery, an Anglo-Indian medicinal chemistry and integrated drug discovery services company with 800+ scientists; and o2h Co-work Labs, a collaborative science and tech workspace designed to nurture innovation. Together, these pillars empower o2h to identify, fund, and scale breakthrough ideas by combining scientific excellence with entrepreneurial execution and global networks.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}